Recognition of Lipopolysaccharide Pattern by TLR4 Complexes
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
TLR3-Dependent Activation of TLR2 Endogenous Ligands Via the Myd88 Signaling Pathway Augments the Innate Immune Response
cells Article TLR3-Dependent Activation of TLR2 Endogenous Ligands via the MyD88 Signaling Pathway Augments the Innate Immune Response 1 2, 1 3 Hellen S. Teixeira , Jiawei Zhao y, Ethan Kazmierski , Denis F. Kinane and Manjunatha R. Benakanakere 2,* 1 Department of Orthodontics, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA 19004, USA; [email protected] (H.S.T.); [email protected] (E.K.) 2 Department of Periodontics, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA 19004, USA; [email protected] 3 Periodontology Department, Bern Dental School, University of Bern, 3012 Bern, Switzerland; [email protected] * Correspondence: [email protected] Present address: Department of Pathology, Wayne State University School of Medicine, y 541 East Canfield Ave., Scott Hall 9215, Detroit, MI 48201, USA. Received: 30 June 2020; Accepted: 12 August 2020; Published: 17 August 2020 Abstract: The role of the adaptor molecule MyD88 is thought to be independent of Toll-like receptor 3 (TLR3) signaling. In this report, we demonstrate a previously unknown role of MyD88 in TLR3 signaling in inducing endogenous ligands of TLR2 to elicit innate immune responses. Of the various TLR ligands examined, the TLR3-specific ligand polyinosinic:polycytidylic acid (poly I:C), significantly induced TNF production and the upregulation of other TLR transcripts, in particular, TLR2. Accordingly, TLR3 stimulation also led to a significant upregulation of endogenous TLR2 ligands mainly, HMGB1 and Hsp60. By contrast, the silencing of TLR3 significantly downregulated MyD88 and TLR2 gene expression and pro-inflammatory IL1β, TNF, and IL8 secretion. The silencing of MyD88 similarly led to the downregulation of TLR2, IL1β, TNF and IL8, thus suggesting MyD88 / to somehow act downstream of TLR3. -
TLR4 and TLR9 Ligands Macrophages Induces Cross
Lymphotoxin β Receptor Activation on Macrophages Induces Cross-Tolerance to TLR4 and TLR9 Ligands This information is current as Nadin Wimmer, Barbara Huber, Nicola Barabas, Johann of September 27, 2021. Röhrl, Klaus Pfeffer and Thomas Hehlgans J Immunol 2012; 188:3426-3433; Prepublished online 22 February 2012; doi: 10.4049/jimmunol.1103324 http://www.jimmunol.org/content/188/7/3426 Downloaded from Supplementary http://www.jimmunol.org/content/suppl/2012/02/23/jimmunol.110332 Material 4.DC1 http://www.jimmunol.org/ References This article cites 42 articles, 13 of which you can access for free at: http://www.jimmunol.org/content/188/7/3426.full#ref-list-1 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision by guest on September 27, 2021 • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2012 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Lymphotoxin b Receptor Activation on Macrophages Induces Cross-Tolerance to TLR4 and TLR9 Ligands Nadin Wimmer,* Barbara Huber,* Nicola Barabas,* Johann Ro¨hrl,* Klaus Pfeffer,† and Thomas Hehlgans* Our previous studies indicated that lymphotoxin b receptor (LTbR) activation controls and downregulates inflammatory reac- tions. -
Osteoarthritis and Toll-Like Receptors: When Innate Immunity Meets Chondrocyte Apoptosis
biology Review Osteoarthritis and Toll-Like Receptors: When Innate Immunity Meets Chondrocyte Apoptosis Goncalo Barreto 1,2,* , Mikko Manninen 3 and Kari K. Eklund 1,2,3 1 Department of Rheumatology, Helsinki University and Helsinki University Hospital, 00014 Helsinki, Finland; kari.eklund@hus.fi 2 Translational Immunology Research Program, University of Helsinki, 00014 Helsinki, Finland 3 Orton Research Institute, 00280 Helsinki, Finland; mikko.manninen@orton.fi * Correspondence: goncalo.barreto@helsinki.fi; Tel.: +358-4585-381-10 Received: 24 February 2020; Accepted: 28 March 2020; Published: 30 March 2020 Abstract: Osteoarthritis (OA) has long been viewed as a degenerative disease of cartilage, but accumulating evidence indicates that inflammation has a critical role in its pathogenesis. In particular, chondrocyte-mediated inflammatory responses triggered by the activation of innate immune receptors by alarmins (also known as danger signals) are thought to be involved. Thus, toll-like receptors (TLRs) and their signaling pathways are of particular interest. Recent reports suggest that among the TLR-induced innate immune responses, apoptosis is one of the critical events. Apoptosis is of particular importance, given that chondrocyte death is a dominant feature in OA. This review focuses on the role of TLR signaling in chondrocytes and the role of TLR activation in chondrocyte apoptosis. The functional relevance of TLR and TLR-triggered apoptosis in OA are discussed as well as their relevance as candidates for novel disease-modifying OA drugs (DMOADs). Keywords: osteoarthritis; chondrocytes; toll-like receptors; apoptosis; innate immunity; cartilage 1. Introduction: The Role of Immunity in OA Clinical osteoarthritis (OA) is preceded by a preclinical stage, which, in conjunction with the presence of risk factors and/or other pathological factors, proceeds to the radiographic OA state. -
Dephosphorylating TRAM TRIF-Dependent TLR4 Pathway by Phosphatase PTPN4 Preferentially Inhibits
Phosphatase PTPN4 Preferentially Inhibits TRIF-Dependent TLR4 Pathway by Dephosphorylating TRAM This information is current as Wanwan Huai, Hui Song, Lijuan Wang, Bingqing Li, Jing of September 29, 2021. Zhao, Lihui Han, Chengjiang Gao, Guosheng Jiang, Lining Zhang and Wei Zhao J Immunol published online 30 March 2015 http://www.jimmunol.org/content/early/2015/03/28/jimmun ol.1402183 Downloaded from Why The JI? Submit online. http://www.jimmunol.org/ • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average by guest on September 29, 2021 Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2015 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Published March 30, 2015, doi:10.4049/jimmunol.1402183 The Journal of Immunology Phosphatase PTPN4 Preferentially Inhibits TRIF-Dependent TLR4 Pathway by Dephosphorylating TRAM Wanwan Huai,* Hui Song,* Lijuan Wang,† Bingqing Li,‡ Jing Zhao,* Lihui Han,* Chengjiang Gao,* Guosheng Jiang,‡ Lining Zhang,* and Wei Zhao* TLR4 recruits TRIF-related adaptor molecule (TRAM, also known as TICAM2) as a sorting adaptor to facilitate the interaction between TLR4 and TRIF and then initiate TRIF-dependent IRF3 activation. -
Genetic Variation of the Toll-Like Receptors in a Swedish Allergic Rhinitis Case Population
http://www.diva-portal.org This is the published version of a paper published in BMC Medical Genetics. Citation for the original published paper (version of record): Henmyr, V., Carlberg, D., Manderstedt, E., Lind-Halldén, C., Säll, T. et al. (2017) Genetic variation of the toll-like receptors in a Swedish allergic rhinitis case population. BMC Medical Genetics, 18(1): 18 https://doi.org/10.1186/s12881-017-0379-6 Access to the published version may require subscription. N.B. When citing this work, cite the original published paper. Permanent link to this version: http://urn.kb.se/resolve?urn=urn:nbn:se:hkr:diva-16592 Henmyr et al. BMC Medical Genetics (2017) 18:18 DOI 10.1186/s12881-017-0379-6 RESEARCHARTICLE Open Access Genetic variation of the Toll-like receptors in a Swedish allergic rhinitis case population V. Henmyr1,2*†, D. Carlberg2†, E. Manderstedt1,2, C. Lind-Halldén2, T. Säll1, L. O. Cardell3 and C. Halldén2 Abstract Background: Variation in the 10 toll-like receptor (TLR) genes has been significantly associated with allergic rhinitis (AR) in several candidate gene studies and three large genome-wide association studies. These have all investigated common variants, but no investigations for rare variants (MAF ≤ 1%) have been made in AR. The present study aims to describe the genetic variation of the promoter and coding sequences of the 10 TLR genes in 288 AR patients. Methods: Sanger sequencing and Ion Torrent next-generation sequencing was used to identify polymorphisms in a Swedish AR population and these were subsequently compared and evaluated using 1000Genomes and Exome Aggregation Consortium (ExAC) data. -
TLR4 Signaling and Macrophage Inflammatory Responses Are Dampened by GIV/Girdin
TLR4 signaling and macrophage inflammatory responses are dampened by GIV/Girdin Lee Swansona, Gajanan D. Katkara, Julian Tama, Rama F. Pranadinataa, Yogitha Chareddya, Jane Coatesa, Mahitha Shree Anandachara, Vanessa Castilloa, Joshua Olsonb, Victor Nizetb,c, Irina Kufarevac, Soumita Dasd, and Pradipta Ghosha,e,1 aDepartment of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA 92093; bDepartment of Pediatrics, University of California San Diego, La Jolla, CA 92093; cSkaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, CA 92093; dDepartment of Pathology, University of California San Diego, La Jolla, CA 92093; and eDepartment of Medicine, University of California San Diego, La Jolla, CA 92093 Edited by Shizuo Akira, Osaka University, Osaka, Japan, and approved September 18, 2020 (received for review June 10, 2020) Sensing of pathogens by Toll-like receptor 4 (TLR4) induces an inflam- and integrins (reviewed in refs. 5, 6), here we studied if and how matory response; controlled responses confer immunity but uncon- GIV may impact the LPS/TLR4 signaling in the most relevant trolled responses cause harm. Here we define how a multimodular cell line, i.e., macrophages. We dissect the relevance of those scaffold, GIV (a.k.a. Girdin), titrates such inflammatory response in findings in murine disease models and its broader relevance macrophages. Upon challenge with either live microbes or microbe- among other TLRs. derived lipopolysaccharides (a ligand for TLR4), macrophages with GIV mount a more tolerant (hypo-reactive) transcriptional response and Results and Discussion suppress proinflammatory cytokines and signaling pathways GIV Is Preferentially Expressed in the Myeloid Cells of Our Immune (i.e., NFkB and CREB) downstream of TLR4 compared to their System. -
CD Markers Are Routinely Used for the Immunophenotyping of Cells
ptglab.com 1 CD MARKER ANTIBODIES www.ptglab.com Introduction The cluster of differentiation (abbreviated as CD) is a protocol used for the identification and investigation of cell surface molecules. So-called CD markers are routinely used for the immunophenotyping of cells. Despite this use, they are not limited to roles in the immune system and perform a variety of roles in cell differentiation, adhesion, migration, blood clotting, gamete fertilization, amino acid transport and apoptosis, among many others. As such, Proteintech’s mini catalog featuring its antibodies targeting CD markers is applicable to a wide range of research disciplines. PRODUCT FOCUS PECAM1 Platelet endothelial cell adhesion of blood vessels – making up a large portion molecule-1 (PECAM1), also known as cluster of its intracellular junctions. PECAM-1 is also CD Number of differentiation 31 (CD31), is a member of present on the surface of hematopoietic the immunoglobulin gene superfamily of cell cells and immune cells including platelets, CD31 adhesion molecules. It is highly expressed monocytes, neutrophils, natural killer cells, on the surface of the endothelium – the thin megakaryocytes and some types of T-cell. Catalog Number layer of endothelial cells lining the interior 11256-1-AP Type Rabbit Polyclonal Applications ELISA, FC, IF, IHC, IP, WB 16 Publications Immunohistochemical of paraffin-embedded Figure 1: Immunofluorescence staining human hepatocirrhosis using PECAM1, CD31 of PECAM1 (11256-1-AP), Alexa 488 goat antibody (11265-1-AP) at a dilution of 1:50 anti-rabbit (green), and smooth muscle KD/KO Validated (40x objective). alpha-actin (red), courtesy of Nicola Smart. PECAM1: Customer Testimonial Nicola Smart, a cardiovascular researcher “As you can see [the immunostaining] is and a group leader at the University of extremely clean and specific [and] displays Oxford, has said of the PECAM1 antibody strong intercellular junction expression, (11265-1-AP) that it “worked beautifully as expected for a cell adhesion molecule.” on every occasion I’ve tried it.” Proteintech thanks Dr. -
TLR9 Gene Transcriptional Regulation of the Human
Transcriptional Regulation of the Human TLR9 Gene Fumihiko Takeshita, Koichi Suzuki, Shin Sasaki, Norihisa Ishii, Dennis M. Klinman and Ken J. Ishii This information is current as of September 30, 2021. J Immunol 2004; 173:2552-2561; ; doi: 10.4049/jimmunol.173.4.2552 http://www.jimmunol.org/content/173/4/2552 Downloaded from References This article cites 49 articles, 31 of which you can access for free at: http://www.jimmunol.org/content/173/4/2552.full#ref-list-1 Why The JI? Submit online. http://www.jimmunol.org/ • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average by guest on September 30, 2021 Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2004 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Transcriptional Regulation of the Human TLR9 Gene1 Fumihiko Takeshita,2* Koichi Suzuki,† Shin Sasaki,‡ Norihisa Ishii,‡ Dennis M. Klinman,* and Ken J. Ishii3* To clarify the molecular basis of human TLR9 (hTLR9) gene expression, the activity of the hTLR9 gene promoter was charac- terized using the human myeloma cell line RPMI 8226. -
RT² Profiler PCR Array (96-Well Format and 384-Well [4 X 96] Format)
RT² Profiler PCR Array (96-Well Format and 384-Well [4 x 96] Format) Human Toll-Like Receptor Signaling Pathway Cat. no. 330231 PAHS-018ZA For pathway expression analysis Format For use with the following real-time cyclers RT² Profiler PCR Array, Applied Biosystems® models 5700, 7000, 7300, 7500, Format A 7700, 7900HT, ViiA™ 7 (96-well block); Bio-Rad® models iCycler®, iQ™5, MyiQ™, MyiQ2; Bio-Rad/MJ Research Chromo4™; Eppendorf® Mastercycler® ep realplex models 2, 2s, 4, 4s; Stratagene® models Mx3005P®, Mx3000P®; Takara TP-800 RT² Profiler PCR Array, Applied Biosystems models 7500 (Fast block), 7900HT (Fast Format C block), StepOnePlus™, ViiA 7 (Fast block) RT² Profiler PCR Array, Bio-Rad CFX96™; Bio-Rad/MJ Research models DNA Format D Engine Opticon®, DNA Engine Opticon 2; Stratagene Mx4000® RT² Profiler PCR Array, Applied Biosystems models 7900HT (384-well block), ViiA 7 Format E (384-well block); Bio-Rad CFX384™ RT² Profiler PCR Array, Roche® LightCycler® 480 (96-well block) Format F RT² Profiler PCR Array, Roche LightCycler 480 (384-well block) Format G RT² Profiler PCR Array, Fluidigm® BioMark™ Format H Sample & Assay Technologies Description The Human Toll-Like Receptor (TLR) Signaling Pathway RT² Profiler PCR Array profiles the expression of 84 genes central to TLR-mediated signal transduction and innate immunity. The TLR family of pattern recognition receptors (PRRs) detects a wide range of bacteria, viruses, fungi and parasites via pathogen-associated molecular patterns (PAMPs). Each receptor binds to specific ligands, initiates a tailored innate immune response to the specific class of pathogen, and activates the adaptive immune response. -
Fcγriib Attenuates TLR4‑Mediated NF‑Κb Signaling in B Cells
MOLECULAR MEDICINE REPORTS 16: 5693-5698, 2017 FcγRIIb attenuates TLR4‑mediated NF‑κB signaling in B cells LI QIAN1-3, WENYAN CHEN1, SHAOQING WANG1, YANG LIU1, XIAOQIN JIA1, YI FU1, WEIJUAN GONG1 and FANG TIAN1 1Department of Immunology, School of Medicine, Yangzhou University, Yangzhou, Jiangsu 225001; 2Jiangsu Key Laboratory of Zoonosis, Jiangsu Co-Innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou, Jiangsu 225009; 3Jiangsu Key Laboratory of Integrated Traditional Chinese and Western Medicine for Prevention and Treatment of Senile Diseases, Yangzhou, Jiangsu 225001, P.R. China Received September 26, 2016; Accepted June 28, 2017 DOI: 10.3892/mmr.2017.7269 Abstract. Toll-like receptors (TLRs) serve a vital role in (TLRs) are triggered to induce pro‑inflammatory cytokines activating the innate immune system by sensing conserved production, thus serving important roles in the initiation of microbial products. Fc γ receptor IIb (FcγRIIb), the inhibitory innate immunity (1). The TLR intracellular signaling pathway Fc receptor, exerts its immune regulatory functions by binding has been studied intensively. Binding of TLR4 agonist, to the immunoglobulin G Fc domain. Although the individual LPS, to TLR4 activates myeloid differentiation protein 88 roles of TLRs and FcγRIIb have been studied intensively, the (MyD88)-dependent signaling, leading to the activation cross-talk between FcγRIIb and TLR4 on B cells remains of mitogen-activated protein kinase (MAPK) and nuclear unknown. The present study demonstrated that FcγRIIb ligation factor (NF)-κΒ pathways, and contributing to the release of by the immune complex (IC) attenuated the TLR4-triggered pro‑inflammatory cytokines (2,3). Increased production of nuclear factor (NF)-κΒ activation, and decreased the release pro‑inflammatory cytokines causes damage to the host and of interleukin (IL)-6 from B cells, via enhancing LYN induces pathological inflammation. -
Bacterial Interactions with Cells of the Intestinal Mucosa: Toll- 1182 Like Receptors and Nod2
Recent advances in basic science BACTERIAL INTERACTIONS WITH CELLS OF THE INTESTINAL MUCOSA: TOLL- 1182 LIKE RECEPTORS AND NOD2 ECario Gut: first published as on 11 July 2005. Downloaded from Gut 2005;54:1182–1193. doi: 10.1136/gut.2004.062794 SUMMARY Toll-like receptors (TLR) and NOD2 are emerging as key mediators of innate host defence in the intestinal mucosa, crucially involved in maintaining mucosal as well as commensal homeostasis. Recent observations suggest new (patho-) physiological mechanisms of how functional versus dysfunctional TLRx/NOD2 pathways may oppose or favour inflammatory bowel disease (IBD). In Published online first 19 April 2005 health, TLRx signalling protects the intestinal epithelial barrier and confers commensal tolerance whereas NOD2 signalling exerts antimicrobial activity and prevents pathogenic invasion. In disease, aberrant TLRx and/or NOD2 signalling may stimulate diverse inflammatory responses leading to acute and chronic intestinal inflammation with many different clinical phenotypes. c INTRODUCTION The intestinal mucosa must rapidly recognise detrimental pathogenic threats to the lumen to initiate controlled immune responses but maintain hyporesponsiveness to omnipresent harmless commensals. Charles Janeway Jr first suggested that so-called pattern recognition receptors (PRRs) may play an essential role in allowing innate immune cells to discriminate between ‘‘self’’ http://gut.bmj.com/ and microbial ‘‘non-self’’ based on the recognition of broadly conserved molecular patterns.1 Toll- like receptors (TLRs) which comprise a class of transmembrane PRRs play a key role in microbial recognition, induction of antimicrobial genes, and the control of adaptive immune responses. NODs (NOD1 and NOD2) are a structurally distinct family of intracellular PRRs which presumably in the context of microbial invasion subserve similar functions (fig 1). -
An Immunologist's Perspective on Nutrition, Immunity, and Infectious
© 2009 Poultry Science Association, Inc. An immunologist’s perspective on nutrition, immunity, and infectious diseases: 1 Introduction and overview M. H. Kogut *2 and K. Klasing † * Southern Plains Agricultural Research Center, USDA-ARS, College Station, TX 77845; and † Department of Avian Sciences, University of California, Davis 95616 Primary Audience: Poultry Nutritionists, Immunologists, Veterinarians, Researchers SUMMARY The immune system is a multifaceted arrangement of membranes (skin, epithelial, and mucus), cells, and molecules whose function is to eradicate invading pathogens or cancer cells from a host. Working together, the various components of the immune system perform a balancing act of being lethal enough to kill pathogens or cancer cells yet specific so as not to cause extensive damage to “self” tissues of the host. A functional immune system is a requirement of a healthy life in modern animal production. Yet infectious diseases still represent a serious drain on the economics (reduced production, cost of therapeutics, and vaccines) and welfare of animal agriculture. The interaction involving nutrition and immunity and how the host deals with infectious agents is a strategic deter- minant in animal health. Almost all nutrients in the diet play a fundamental role in sustaining an op- timal immune response, such that deficient and excessive intakes can have negative consequences on immune status and susceptibility to a variety of pathogens. Dietary components can regulate physiological functions of the body; interacting with the immune response is one of the most im- portant functions of nutrients. The pertinent question to be asked and answered in the current era of poultry production is whether the level of nutrients that maximizes production in commercial diets is sufficient to maintain competence of immune status and disease resistance.